Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.88M Buy
22,162
+3,652
+20% +$293K 1.15% 13
2026
Q1
$1.55M Buy
18,510
+4,494
+32% +$339K 1.09% 22
2025
Q4
$939K Buy
+14,016
New +$906K 0.73% 28

Other funds holding CTVA

Trium Capital's CTVA Position: Q2 2026 in Review

Trium Capital increased its Corteva (CTVA) stake by 20% in Q2 2026, buying an estimated $293K and bringing the position to 22,162 shares worth $1.88M. The position accounts for 1.15% of the portfolio, ranked #13.

Trium Capital first reported a position in CTVA in Q4 2025 and has held it in 3 quarters since. 231 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

  • Trium Capital held 22,162 shares of Corteva worth $1.88M as of Q2 2026.
  • Trium Capital bought 3,652 Corteva shares in Q2 2026, an estimated $293K.
  • Corteva made up 1.15% of Trium Capital's portfolio in Q2 2026, its #13 holding.
  • Trium Capital first reported a position in Corteva in Q4 2025 and has held it in 3 quarters since.
  • 231 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on Trium Capital's 13F filing for Q2 2026, filed 16 Jul 2026.